NPI registry status
Active
2026 NPPES data Otolaryngology Physician NPI 1164431953 MD
Verify on CMS → Steven Bielamowicz, MD
Otolaryngology Physician in Washington, District of Columbia.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 10,893 in Otolaryngology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
279
Medicare Part D claims · 87 beneficiaries · Otolaryngology Physician avg: 509
Generic prescribing
94%
generic claims · 6% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$21.78
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Steven Bielamowicz, MD filed 279 Medicare Part D claims in 2023 as an Otolaryngology Physician in Washington, District of Columbia, prescribing 94% generic.
- 279
- Part D claims, 2023
- 94%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥49th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1164431953 · Otolaryngology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1164431953
- ENUM-LEGACY 2006
- TAX-MID 11K Otolaryngology Physician
- RX-LIGHT 279
- BOOK-THIN 49 in District of Columbia
- PHOTO-ENUM Harvey Freedman · 2006
Steven Bielamowicz, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
279 ≥ 49th percentile 49% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Steven Bielamowicz, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Steven Bielamowicz, MD?
Quality data not reportedPrimary specialty
Otolaryngology Physician
Medicare Part D claims
279 45% vs specialty avg
Specialty distribution in District of Columbia
How Otolaryngology Physician compares to other specialties among District of Columbia providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Otolaryngology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1164431953 |
|---|---|
| Specialty | Otolaryngology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 08/08/2006 |
Hospital and facility affiliations
Facilities where Steven Bielamowicz, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Medical Faculty Associates, Inc
Washington, DC
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Steven Bielamowicz, MD. Source: openpaymentsdata.cms.gov.
Total received
$22
Largest payer
Integra LifeSciences Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
Steven Bielamowicz, MD - brand share 6.0%
Otolaryngology Physician average
6% brand-name claims vs 94% generic, on 279 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
279
Total Claims
$11K
Total Drug Cost
87
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 583
- Total Day Supply
- 17,142
- Brand vs Generic
- 6% brand / 94% generic
- Brand Drug Cost
- $5K
- Generic Drug Cost
- $6K
- Opioid Claims
- 11 (3.9% rate)
Patient Demographics
- Average Patient Age
- 70.9 years
- Avg HCC Risk Score
- 1.24
- Gender Split
- 63% female / 37% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Steven Bielamowicz, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Pantoprazole Sodium
Pantoprazole Sodium
124 claims
- Amitriptyline Hcl 22
Amitriptyline Hcl
22 claims
- Omeprazole 19
Omeprazole
19 claims
- Propranolol Hcl 16
Propranolol Hcl
16 claims
- Famotidine 12
Famotidine
12 claims
- Glycopyrrolate 11
Glycopyrrolate
11 claims
| Drug | Claims |
|---|---|
| Pantoprazole Sodium | 124 |
| Amitriptyline Hcl | 22 |
| Omeprazole | 19 |
| Propranolol Hcl | 16 |
| Famotidine | 12 |
| Glycopyrrolate | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Otolaryngology Physician Overview
How Steven Bielamowicz, MD fits within the Otolaryngology Physician landscape nationally.
10,893
Otolaryngology Physician Providers in US
54
States with Otolaryngology Physician
509
Avg Claims per Provider
Steven Bielamowicz, MD's 279 claims are below the specialty average of 509.
Nationwide Otolaryngology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Bielamowicz, both outside District of Columbia so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Otolaryngology Physician Providers in District of Columbia
Other clinicians with the same primary specialty enrolled in District of Columbia, drawn from the same CMS NPPES roster as Bielamowicz.
One of 49 Otolaryngology Physician providers enrolled in District of Columbia, 5 are shown here.
Miguel Acevedo
Washington, DC
Dr. Richard Albert
M.D., D.D.S.
Washington, DC
Dr. Mark Alexander
M.D.
Washington, DC
Dr. William Bond
M.D. MBA
Washington, DC
Dr. Joseph Chapman
M.D.
Washington, DC
Compare Otolaryngology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Steven Bielamowicz, MD's specialty? ▼
Steven Bielamowicz, MD specializes in Otolaryngology Physician and practices in Washington, District of Columbia. Credentials: MD.
How much does Steven Bielamowicz, MD prescribe under Medicare Part D? ▼
In 2023, Steven Bielamowicz, MD wrote 279 Medicare Part D claims totaling $11K in drug costs for 87 beneficiaries.
Where is Steven Bielamowicz, MD located? ▼
Steven Bielamowicz, MD is located at 2300 M ST NW FL 4, Washington, DC, 20037. Phone: (202) 741-3260.
What is Steven Bielamowicz, MD's NPI number? ▼
Steven Bielamowicz, MD's National Provider Identifier (NPI) is 1164431953, issued on 08/08/2006.
Does Steven Bielamowicz, MD prescribe more brand-name or generic drugs? ▼
Steven Bielamowicz, MD's prescribing is 6% brand-name and 94% generic drugs by claim count, with $5K in brand drug costs.
Does Steven Bielamowicz, MD prescribe opioids? ▼
Yes, Steven Bielamowicz, MD had 11 opioid claims in 2023 with an opioid prescribing rate of 3.9%.
How many Otolaryngology Physician providers are there in the US? ▼
There are 10,893 Otolaryngology Physician providers across 54 states in the US. The average Otolaryngology Physician provider writes 509 Medicare Part D claims per year.
What drugs does Steven Bielamowicz, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Steven Bielamowicz, MD's most frequently prescribed drugs include Pantoprazole Sodium, Amitriptyline Hcl, Omeprazole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Steven Bielamowicz, MD accept Medicare? ▼
Steven Bielamowicz, MD appears in CMS Medicare data with 279 Part D claims and 87 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Steven Bielamowicz, MD's credentials? ▼
Steven Bielamowicz, MD's NPI is 1164431953 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.